Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,319 INR | -0.35% | +1.06% | -14.81% |
Feb. 19 | Clean Science Arm Inaugurates New Manufacturing Unit in Pune, India | MT |
Feb. 03 | Transcript : Clean Science and Technology Limited, Q3 2024 Earnings Call, Feb 03, 2024 |
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 56% by 2026.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 59.12 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.81% | 1.68B | C | ||
+13.15% | 64.66B | A- | ||
-3.80% | 46.08B | A- | ||
+13.26% | 39.72B | B+ | ||
+19.28% | 25.82B | A- | ||
+8.22% | 18.8B | C+ | ||
-0.50% | 17.14B | B+ | ||
-21.03% | 15.86B | A- | ||
+1.06% | 15.05B | B+ | ||
-17.55% | 14.14B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLEAN Stock
- CLEAN Stock
- Ratings Clean Science and Technology Limited